Litigation Details for ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
✉ Email this page to a colleague
ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-07-30 |
| Court | District Court, D. Delaware | Date Terminated | 2024-01-11 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 7,601,740; 7,732,615 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-07-30 | 1 | Complaint | United States Patent Nos. 7,732,615 (“the ’615 patent”) and 10,646,480 (“the ’480 patent”) (collectively…collectively “the patents-in-suit”). This action arises under the Patent Laws of the United States, 35 U.S.C.…ACADIA owns the ’615 patent. 26. On May 12, 2020, the ’480 patent, entitled “Formulations…of the ’480 patent is attached as Exhibit B. 27. ACADIA owns the ’480 patent. … respect to the patents-in-suit constituted an act of infringement of those patents. 43. | External link to document |
| 2020-09-30 | 11 | Counterclaim AND Answer to Complaint | claim of U.S. Patent No. 7,732,615; (c) declaring that the claims of U.S. Patent No. 7,732,615 are invalid….S. Patent Nos. 7,732,615 (“the ’615 patent”) and 10,646,480 (“the °480 patent”) under the Patent Laws…United States Patent Nos. 7,732,615 (“the °615 patent”) and 10,646,480 (“the ’480 patent”) (collectively…infringement of U.S. Patent Nos. 7,732,615 (“the ’615 patent”) and 10,646,480 (“the ’480 patent”) arising under… any valid and enforceable claim of U.S. Patent No. 7,732,615; (b) declaring that the manufacture, use | External link to document |
| 2020-11-04 | 17 | Complaint - Amended | States Patent Nos. 7,732,615 (“the ’615 patent”), 10,646,480 (“the ’480 patent”), and 7,601,740 (“the …the ’740 patent”) (collectively “the patents-in-suit”). This action arises under the Patent Laws of the…ACADIA owns the ’615 patent. 26. On May 12, 2020, the ’480 patent, entitled “Formulations…of the ’480 patent is attached as Exhibit B. 27. ACADIA owns the ’480 patent. …of the ’740 patent is attached as Exhibit C. 29. ACADIA owns the ’740 patent. | External link to document |
| 2020-11-04 | 19 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,732,615 ;10,646,480 ;7,601,740 . (Taylor… 30 July 2020 1:20-cv-01029 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-07-30 | 3 | ANDA Form | Date of Expiration of Patent: Patent No. 7,732,615 – June 3, 2028 … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: June 18, 2020. Date of Expiration of Patent: SEE ATTACHED FORM.Thirty Month Stay Deadline: … SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW … Patent No. 10,646,480 – August 27, 2038 Thirty | External link to document |
| 2020-07-30 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,732,615 and 10,646,480. (amf…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 7,732,615 … G ✔ Patents. ( G the patent action involves 35 U.S.C. § 292.): …PHARMACEUTICALS, INC. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
